Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Ophthalmology
Published in: BMC Ophthalmology 1/2015

Open Access 01-12-2015 | Case report

Bilateral cystoid macular edema following docetaxel chemotherapy in a patient with retinitis pigmentosa: a case report

Authors: Anna Enzsoly, Kinga Kammerer, Janos Nemeth, Miklos Schneider

Published in: BMC Ophthalmology | Issue 1/2015

Login to get access

Abstract

Background

Docetaxel is a chemotherapeutic agent of the taxane class of drugs for the treatment of breast cancer. We present a female patient who noted decreased vision after docetaxel treatment.

Case presentation

A 45-year-old female patient received docetaxel treatment after resection of a breast carcinoma. Funduscopy and optical coherence tomography (OCT) showed cystoid macular edema on both eyes. Dilated funduscopy also showed bone spicule-like pigmented deposits, typical for retinitis pigmentosa. Besides the fundus appearance restricted peripheral vision and scotopic electroretinogram confirmed the diagnosis of retinitis pigmentosa. Chemotherapy was discontinued following a consulation with the oncologist of the patient. After five weeks, visual acuity improved significantly along with decrease of retinal thickness measured by OCT.

Conclusion

Docetaxel may cause ocular adverse effects such as cystoid macular edema. Ophthalmological examination is warranted for patients with visual complaints during docetaxel chemotherapy.
Literature
1.
2.
Vámos R, Tátrai E, Németh J, Holder GE, DeBuc DC, Somfai GM. The structure and function of the macula in patients with advanced retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2011;52(11):8425–32.CrossRefPubMedPubMedCentral
3.
Witkin AJ, Ko TH, Fujimoto JG, Chan A, Drexler W, Schuman JS, et al. Ultra-high resolution optical coherence tomography assessment of photoreceptors in retinitis pigmentosa and related diseases. Am J Ophthalmol. 2006;142(6):945–52.CrossRefPubMedPubMedCentral
4.
Sahel J, Bonnel S, Mrejen S, Paques M. Retinitis pigmentosa and other dystrophies. Dev Ophthalmol. 2010;47:160–7.CrossRefPubMed
5.
Murphy CG, Walsh JB, Hudis CA, Lake D, Theodoulou M. Cystoid macular edema secondary to nab-paclitaxel therapy. J Clin Oncol. 2010;28(33):e684–7.CrossRefPubMed
6.
Teitelbaum BA, Tresley DJ. Cystic maculopathy with normal capillary permeability secondary to docetaxel. Optom Vis Sci. 2003;80(4):277–9.CrossRefPubMed
7.
Kuznetcova TI, Cech P, Herbort CP. The mystery of angiographically silent macular oedema due to taxanes. Int Ophthalmol. 2012;32(3):299–304.CrossRefPubMed
8.
9.
10.
Padrón Pérez N, Rubio Caso MJ, Arias Barquet L, Caminal Mitjana JM. Bilateral cystoid macular edema in a patient with taxane-based chemotherapy. Can J Ophthalmol. 2013;48(1):e3–4.CrossRefPubMed
11.
Telander DG, Sarraf D. Cystoid Macular Edema with Docetaxel Chemotherapy and the Fluid Retention Syndrome. Semin Ophthalmol. 2007;22(3):151–3.CrossRefPubMed
12.
Smith SV, Benz MS, Brown DM. Cystoid macular edema secondary to albumin-bound paclitaxel therapy. Arch Ophthalmol. 2008;126(11):1605–6.CrossRefPubMed
13.
Makiyama Y, Oishi A, Otani A, Ogino K, Nakagawa S, Kurimoto M, et al. Prevalence and spatial distribution of cystoid spaces in retinitis pigmentosa: investigation with spectral domain optical coherence tomography. Retina. 2014;34(5):981–8.CrossRefPubMed
14.
Chaudhry V, Chaudhry M, Crawford TO, Simmons-O’Brien E, Griffin JW. Toxic neuropathy in patients with pre-existing neuropathy. Neurology. 2003;60(2):337–40.CrossRefPubMed
15.
Blanchet P, Wellemeyer ML, Burton GV. Case report: retinitis pigmentosa following cytotoxic chemotherapy in Usher’s syndrome. Am J Med Sci. 1992;303(5):319–20.CrossRefPubMed
16.
Scaioli V, Caraceni A, Martini C, Curzi S, Capri G, Luca G. Electrophysiological evaluation of visual pathways in paclitaxel-treated patients. J Neurooncol. 2006;77(1):79–87.CrossRefPubMed
17.
18.
Reidel B, Goldmann T, Giessl A, Wolfrum U. The translocation of signaling molecules in dark adapting mammalian rod photoreceptor cells is dependent on the cytoskeleton. Cell Motil Cytoskeleton. 2008;65(10):785–800.CrossRefPubMed
19.
Oishi A, Ogino K, Makiyama Y, Nakagawa S, Kurimoto M, Yoshimura N. Wide-field fundus autofluorescence imaging of retinitis pigmentosa. Ophthalmology. 2013;120(9):1827–34.CrossRefPubMed
Metadata
Title
Bilateral cystoid macular edema following docetaxel chemotherapy in a patient with retinitis pigmentosa: a case report
Authors
Anna Enzsoly
Kinga Kammerer
Janos Nemeth
Miklos Schneider
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2015
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-015-0020-4

Other articles of this Issue 1/2015

BMC Ophthalmology 1/2015 Go to the issue

Research article

Long-term outcomes of argon laser photocoagulation in small size cyclodialysis cleft

Research article

Evaluation of real-world mobility in age-related macular degeneration

Research article

Role of Dectin-1 in the innate immune response of rat corneal epithelial cells to Aspergillus fumigatus

Research article

Progression of lower and higher-order aberrations: a longitudinal study

Research article

Photodynamic therapy versus anti-vascular endothelial growth factor agents for polypoidal choroidal vasculopathy: A meta-analysis

Research article

Effects of refractive errors on visual evoked magnetic fields